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ABSTRACT 
Rabbit antiserum was prepared aga inst crystalline hen egg white and huma n milk lyso-
zymes. The immunologica l c ross-reactio ns among egg wh ite lysozy m e a nd human lysozymes 
(skin , milk, leu cocyte a nd crude tears) were studied by the quali tative gel diffus ion precip-
itation technique and quantitative n eu tra li zation test using anti-E.W.L. Serum and anti-
H.M.L. Serum . Immunological ide n t ity of t he hum a n s kin lysozyme w ith both t h e huma n 
milk a nd leu cocyte lysozymes and nonidentity of it with E.W.L. were d emonstrated . 
T he bactericidal and fungicidal properties of 
· the skin t issu es have been attr ibu ted to t he pres-
ence of various biologica l materials. Recen t ly, 
Klenha and Krs (1) have determined t he lytic ac-
tivity of hairl ess mouse sk in and hum a n skin sur-
faces against Micrococcus lysodeikticus (M.L.) 
cells. 
They have a lso provided ev id en ce t hat t his ac -
' tiv ity is due to skin lysozyme. This enzyme may 
be considered as a protective agent in resistance 
to infectio n , s ince t he ce ll walls of bacte ria a re 
susceptible to t he lysozy m e. 
More recently, we have isolated a nd purified 
huma n s kin lysozyme (2). In compar in g t h e 
amino ac id a na lys is of purified huma n s kin lyso-
zyme with t h ose of hum a n milk a nd leucocyte 
lysozymes, it was su ggested t hat molecular stru c-
tures of these en zymes might be closely re lated to 
each oth e r . 
We now report t hat human skin lysozyme is 
immuno logica lly id enti ca l with both human milk 
and leu cocyte lysozy m es. 
MATERIALS AND METHODS 
Lysozyme . Human skin lysozyme (H.S.L.) was pre-
pared by the method of Ogawa et al. (2). Human mi lk 
lysozyme (H.M.L.) and leucocyte lysozyme (H.L.L.) 
were prepa red by the method of Kimura et ol. (3). Hen 
egg whi te lysozyme (E. W. L.) was obta ined from Seika -
gaku Kogyo Co., Tokyo (6 x recrystallized Lot No. 
4211) . 
Immunization. Antiserum to E.W.L. or H.M.L. was 
obta ined by immuni zing rabbits with each lysozy me 
mixed with F reund's complete adjuvants. Two mg or 
E. w.L. or H.M.L. were emulsifi ed with equal volum es 
of Freund 's complete adjuvant and adu lt rabbits were 
injected with 2 mg of antigen in to the loot pads. Rab-
bits were each given two booster injections intracuta-
neously with 1 mg of antigen in PBS in the fourth and 
s ixth weeks of a course of immuni zat ion. 
Gel diffusion experiment. Gel diffusion precip itation 
was carried ou t essent ia lly as described by Ochter lony. 
Difco Noble aga r was used at a concentrat ion of 1 per 
cent in PBS. 
Merthiolate at a final concentration of I.: 10,000 was 
added as a preservative. 
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Inactivation of anti-lysozyme sera by homologous and 
heterologous lysozymes. Twofold seria l dilutions of anti-
sera were made in a volume of 0.2 ml, and an equal 
volume of enzy me solu tion, at a concentration of 2.0 11g 
in 0.2 ml PBS, was added to each tube. 
The reaction mixtures were t hen incubated at 35° C 
for 30 minutes. As controls, 0.2 ml of PBS was used in 
pl ace or antise rum solution, and 0.2 ml of PBS was 
added to each tube in place of the enzyme solution, 
because rabbit antisera contain thei r own lysozyme. 
Enzym e assay. Lysozyme activ ity was determined by 
the method previol.)s ly described , with a slight modifica-
tion based upon lys is of the suspension of lyophili zed 
ce lls of M.L. T he freeze dried cells of M.L. (0.25 mg) 
were suspended in one mi liliter of 0.067 M phosphate 
butler pH 6.2, contain ing 0.075 M Na I. The mixture 
was preincubated for 3 minutes at 35° C, before use. To 
3.0 ml of the assay mixture 0.4 ml of the reaction (an-
t ige n-antibody) solu tion was added. The decrea e of 
turbidity at 540 m 11 was measured at 1, 3 and 5 min-
utes. Lysozy me content was ca lcu lated from the enzy-
matic activ ity (t.T/10 min). 
Lyso -plated assay method. Lyso-plated was assayed 
by the methods of Osserma n et al. with a slight modifi -
cation . Lyophili zed M.L. cells, suspended uniformly in 
a sma ll volume or phosphate buffer, were added to 
molten (80- 90° C) 1% agar in PBS at a fina l concentra-
t ion of 30 mg of cells in 100 ml of buffered agar, and 
th en poured into Petri dishes to a height of 3 to 4 mm. 
After the agar solidi fied, sa mple wells, 6 mm in diame-
ter, were cut with a t.hin -wall ed glass tube with a bev-
eled cutting edge. Tbe sample wells were filled with 
approx imately 0. 1 ml of sa mples by capillary tubes. 
Egg white lysozy me, hum an milk lysozyme and each 
of these antisera were tested . The plates were left. at 4o 
C for 2 to 5 days, during which period clear zones devel-
oped in the gel as a result of bacteria l lysis. 
RESULTS 
In ge l d iffus ion experiments, when a ntiserum to 
H.M.L. was p laced in the central well with sev-
era l a n tigen s in the outer we ll s, as indicated in 
Figure 1, a single precipitin lin e was demon-
strated agai nst homologous a nti gen a nd t he other 
huma n lysozymes showing a fusion of line without 
spur fo rmation. 
The a nti -H .M.L. serum did n ot form a n y pre-
cipitin band against E. W.L. (Fig. 1, left). On t he 
oth e r ha nd , a nti se ra prepared to E.W.L. reacted 
onl y with h o mol ogou s a ntigen a nd not with 
human lysozymes. (Fig. 1, ri gh t) 
Various dilutions of anti-H.M.L. serum, were 
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F1c. 1. Gel d iffus ion precipitation experiments of anti-hen egg white lysozyme serum aga inst, hen egg white lyso 
zym e and human lyso1.y mes (ri ght) and of a nti -huma n milk lysozy me serum aga ins t hen egg white lysozyme an~ 
human lysozymes (left). E.W.L. hen egg white lysozy me; H.S.L., human s kin lysozy me; H.M .L., huma n mi lk lyso 
zy me; H.L.L., human leucocytes !ysozy me ; H.T.L., huma n tear lysozy me; A.E.W.L.S., a nt i-hen egg white l ysozylll~ 
rabbit serum ; A.H .M .L.S., anti -human mi lk lysozy me rabbit se rum. 
mixed with equal volum es of lysozyme solution of 
each human skin , mi lk a nd leucocyte lysozyme. 
The lytic act. ivi ty of the reaction mixtures agains t 
M.L. cells was assayed. 
The human skin lysozyme and the other human 
lysozymes we re completely inhibited by anti -
H.M.L. serum at a highest di lution of 1 : 16, and 
fifty p ercent inhibiti ons were shown at a dilution 
of 1:64, while huma n lysozymes were not neutral-
ized with an ti:E.W.L. serum. 
Moreover, t hree inhibition curves were shown 
to be identical (Figure 2). 
On t he other ha nd , the E.W.L. was not neutral -
ized with anti-H.M.L. serum but it was inhi bited 
by a nt i-E. W.L. semm. 
Several concen trations of human skin lysozyme 
placed in we lls on the lyso-plate demons trated 
clear lytic plaques as shown in Figure 3. S izes of 
the plaques produced were proportiona l to the 
concentrations of lysozy me. 
On the lyso-plate, the lyt ic activity of E.W.L. 
was definitel y inhibited by a nti -E.W.L. serum, 
while huma n lysozy mes were not inhibi ted by this 
antiserum (le ft s ide, Fi g. 4). The inhibition zones 
of the lytic activities of H. S.L., H.M.L. a nd 
H.L.L. were dem onstrated on t he lyso-plate by 
a n ti-H.M.L. se rum , but lytic activity or E.W.L. 
was not inf'luenced by thi s a n tise rum (ri ght. s ide). 
DISCUSSION 
The a mino a cid composition of lysozymes iso-
lated from human mi lk, skin a nd leucocy te has 
been shown in previous studies to be s imilar (2). 
The immunologica l s imila rity or identi ty of th e 
H.S .L. with both t he H .M.L. a nd H .L.L, was a lso 
demonstrated in th is s tudy . These data, along 
with the immunological evidence, suggest simi -
larity or identity of the lysozymes in all huma n 
tissues a nd secretions. 
Osse rman et al. (4) have reported thal a nti -
serum to urinary lysozy me which was isola ted 
from Monocy ti c leukemia, crossreacted with 
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DILUTION OF anti - H.M.L.S . 
F 1G. 2. inhibi t ion of hum a n lysozy rn es by anti, 
human milk lysozyme serum . Dilutions (0.2 ml) of anl i, 
huma n mi lk lysozy me serum (l :: to 1 : 1024) wi th PBS 
were mi xed with 0.2 ml of lysozy me solu tion (2.0 11g in lh 
M phosphate buller, pH 6.2). After in cubation (for 30 
minutes at 35°C), the mixture was added to 3.0 ml of 
M . lysodeikticus cell suspens ion in y, , M phosphatP 
buffer, pH 6.2, conta ining NaCl. The reaction mixturP 
was in cubated at 35° C for 5 minutes. After in cubation, 
the turbidity was measured at 540 m}J . T he lytic ac-
t ivity was indi ca ted as th e decrease of the turbiditv. 
The acLivity of the huma n lysozy me without antiseruiu 
was presen ted as ze ro pe rcent ol' inhibiti on. HML: 
0 --0 , HSL; 0-- 0 ., HLL; 6--6. 
H.M.L., buffy coa t, and crude tea rs, but did no\ 
react with E. W.L. 
They a lso repo rted that these antisera (again t 
urinary lysozyme) inhibi ted the enzy me activitie 
or H.M.L. , buffy coa ts and crud e tears, but did 
not inhibi t E. W.L. Th ese data were obta in ed bl' 
ML-P iate a nd Ouchterl ony's doub le dif'fusio;, 
technique. 
fn thi s paper we have studied immunological 
s imilar ity amo ng huma n lysozy mes by the use of 
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FIG. 3. Demonstration of lyti c act. ivit.ies of J-! .S.L. Lyso- pl at e assay method, wi t.h M . /ysodeikticus incorporated 
in PBS agar ge l. Sa mpl es (0.1 ml) were placed 1n wells, 6mm 111 dm meter, a n? the plate photographed after 3 days 
at 4° C. Da rk zones a round sa n~ pl e wells were zones of clea nng due to bacte rra l lys is. a nd were pmportlonal to the 
concent ra tion of lysozy me protems (1 -y/ rnl t.o 50 -y / ml ). 
FIG . 4. Lyso- plat.e demonstra tion of inhibition of the lysozyme activity of E. W.L. by ant i-E. W.L. serum , while 
human lysozym e was not inhibited by this a ntiserum (left side). 
The inhibition zones of the lytic activities of huma n lysozymes were demonst rated on the lyso-plate by anti -
H.M.L. serum , but. lyti c act.ivit.y of E. W.L. was not. influenced by t his a nt iserum (right sid e) . Each enzy me concen -
t ra tion was about. 5 -y/ml. As a cont rol, norma l rabbi t. serum was put. in the well. Photographed afte r 3 days at 4° C. 
normal human milk a nt ise rum quant itat ive ly 
(Fig. 2). 
More recently, J oll es e t al. (5) have suggested 
t hat H .L.L. a re less common with E. W.L. tha n 
with H.M.L. in the immunologica l ana lyses, and 
they also suggest that slight immunologica l differ-
ences exis t a mong human tysozy mes. 
In our obse rvations, however, it was shown that 
human lysozy mes cross- reac ted with each other as 
fa r as the immun ologica l method s used . At 
present the ro le of lysozy mes in th skin or other 
organs is not known. Sin ce it is very diffi cul t to 
get enough lysozy me from skin , it may be pos-
sible to u ti li ze the mil k lysozy me in place of the 
skin lysozyme for the immunologica l stud ies of 
human skin. 
Fluorescent ant ibody for H.M.L. should pro-
vide the evidence for t he cont ri but ion of the skin 
lysozy me to the protective mechanism of skin tis-
sues. 
These immunologica l studies of human skin 
lysozy me are in prog ress in our laboratory. 
We a re indebted to P rofessor Y. Fukazawa for his 
crit ical reviews of the ma nuscript. 
62 THE JOURNAL OF INVESTIGATIVE DERMATOLOGY 
R EFERENCE S 
1. I<Ienha, J. a nd Krs, V.: Lysozy m e in mouse a nd 
huma n skin . J . Invest. Derm ., 49: 396, 1967. 
2. Ogawa, H ., Miyaza ki , H . a nd Kimura, M .: Isola tion 
a nd c ha racte ri zat ion of huma n skin lysozym e. J. 
In ves t. D e rm ., 57: 111, 1971. 
3. Kimura, M. , O ta ki, N., Oga wa, H., Murayam a, K. 
a nd K obayashi , S. : Nat . lnst. Ind . Healt h , 8: 22, 
1970. 
4. Osserma n, E. F. a nd Lawl_or, D. P. : Serum a nd uri. 
nary lysozy me (mura m •dase) 1n m onocytic anq 
monom yelocytic leuke mia . J. E xp. M ed . 124: 9?' 
1966. ' -<, 
5. M a ron , E ., Arnon , R , . Sela, M ., P e rin , J.P. an(j 
J olles, P .: lmmunologJca l co m pa rison o f bird anq 
hl;lma n lysozym es a nd of the ir " loop" region 
B• och1m. Bwphys. Acta, 214: 222, 1970. · 
